55 results on '"Georg, Petra"'
Search Results
2. Prospective Analysis of Radiation-Induced Contrast Enhancement and Health-Related Quality of Life After Proton Therapy for Central Nervous System and Skull Base Tumors
3. Particle Radiotherapy
4. New developments in radiation oncology for head and neck cancers
5. Preservation of Neurocognition after Proton Beam Radiation Therapy for Intracranial Tumors: First Results from REGI-MA-002015
6. Proton or Carbon Ion Therapy for Skull Base Chordoma: Rationale and First Analysis of a Mono-Institutional Experience
7. Meningioma WHO I with involvement of the optical structures—does proton therapy lead to changes in quality of life with regard to subjective visual performance?
8. The trends and significance of SSTR PET/CT added to MRI in follow-up imaging of low-grade meningioma treated with fractionated proton therapy
9. Organs at risk dose constraints in carbon ion radiotherapy at MedAustron: Translations between LEM and MKM RBE models and preliminary clinical results
10. Normofractionated and moderately hypofractionated proton therapy: comparison of acute toxicity and early quality of life outcomes
11. Possibilities and challenges when using synthetic computed tomography in an adaptive carbon-ion treatment workflow
12. A year of pandemic for European particle radiotherapy: A survey on behalf of EPTN working group
13. Current practice in proton therapy delivery in adult cancer patients across Europe
14. Activation of efficient DNA repair mechanisms after photon and proton irradiation of human chondrosarcoma cells
15. Carbon Ion Dose Constraints in the Head and Neck and Skull Base: Review of MedAustron Institutional Protocols
16. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study
17. Particle therapy in head and neck cancer—expanding therapeutic options
18. Harmonization of proton treatment planning for head and neck cancer using pencil beam scanning: first report of the IPACS collaboration group
19. Sequential [18F]FDG-[18F]FMISO PET and Multiparametric MRI at 3T for Insights into Breast Cancer Heterogeneity and Correlation with Patient Outcomes: First Clinical Experience
20. Impact of hybrid PET/MR technology on multiparametric imaging and treatment response assessment of cervix cancer
21. Association between pathology and texture features of multi parametric MRI of the prostate
22. Changes in Tumor Biology During Chemoradiation of Cervix Cancer Assessed by Multiparametric MRI and Hypoxia PET
23. Dose–volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study
24. Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study
25. Impact of organ shape variations on margin concepts for cervix cancer ART
26. Multiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study
27. Dose Volume Effect Relationships (D0.1cm3, D2cm3) Predicting Late Rectal Morbidity in Patients Treated with Concomitant Chemoradiation and MRI-Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: A Report from the EMBRACE Study
28. Feasibility of dominant intraprostatic lesion boosting using advanced photon-, proton- or brachytherapy
29. Development of Clinical Programs for Carbon Ion Beam Therapy at MedAustron
30. Evaluation of planning aims and dose prescription in image-guided adaptive brachytherapy and radiochemotherapy for cervical cancer: Vienna clinical experience in 225 patients from 1998 to 2008
31. PET/MRI in cervical cancer: Insights into tumor biology.
32. Dosimetric Considerations to Determine the Optimal Technique for Localized Prostate Cancer Among External Photon, Proton, or Carbon-Ion Therapy and High-Dose-Rate or Low-Dose-Rate Brachytherapy
33. Magnetic resonance imaging for assessment of parametrial tumour spread and regression patterns in adaptive cervix cancer radiotherapy
34. Uncertainty analysis for 3D image-based cervix cancer brachytherapy by repetitive MR imaging: Assessment of DVH-variations between two HDR fractions within one applicator insertion and their clinical relevance
35. In Reply A. Sharma et al
36. Dose Effect Relationship for Late Side Effects of the Rectum and Urinary Bladder in Magnetic Resonance Image-Guided Adaptive Cervix Cancer Brachytherapy
37. In Response to Dr. Wei and Colleagues
38. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer
39. Assessment of Bladder Dose Location in MRI Guided Adaptive Cervical Cancer Brachytherapy
40. Dose–Volume Histogram Parameters and Late Side Effects in Magnetic Resonance Image–Guided Adaptive Cervical Cancer Brachytherapy
41. Dose volume parameter D2cc does not correlate with vaginal side effects in individual patients with cervical cancer treated within a defined treatment protocol with very high brachytherapy doses
42. Dose–effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy
43. Dose–Volume Histogram Parameters and Local Tumor Control in Magnetic Resonance Image–Guided Cervical Cancer Brachytherapy
44. Correlation of dose–volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy
45. Assessment of Improved Organ at Risk Sparing for Advanced Cervix Carcinoma Utilizing Precision Radiotherapy Techniques
46. Uncertainties in assessing sigmoid dose volume parameters in MRI-guided fractionated HDR brachytherapy
47. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer
48. Uncertainties in Assesment of the Vaginal Dose for Intracavitary Brachytherapy of Cervical Cancer using a Tandem-ring Applicator
49. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Clinical feasibility and preliminary results
50. Inverse Planning – a Comparative Intersystem and Interpatient Constraint Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.